Futuremeds Sp. z o.o. — Clinical Trial Site

164 Registered trials

153 Currently recruiting

Organisation

Futuremeds Sp. z o.o.

Location

Warsaw, Poland

Identifier

ORG-100040258

Address

Ul. Wladyslawa IV 59, 81-384, Poland

Departments

.
# 305 Centrum Medyczne AMED Oddzial w Lodzi
#301 Centrum Medyczne AMED Warszawa Targowek
#3028: Cardiology
#309 Futuremeds Warszawa Centrum
#310 FutureMeds Wroclaw
#40041: CENTRUM MEDYCZNE AMED Warszawa Targowek
#616004; neurology
#616005 Neurologia
#7802: Rheumatology
#7805: Rheumatology
203: FutureMeds Olsztyn
204: FutureMeds Olsztyn
206-FutureMeds Warszawa Centrum
207-FutureMeds Targówek
3006: Cardiology
3027:Cardiology
404_Futuremeds Łodz
406_FutureMeds Gdynia
616003: neurology
616016: FutureMeds Krakow
8526:Cardiology
8527:Futuremeds Olsztyn
Cardiology
cardiology department
Centrum Medyczna AMED Warszawa Targówek
Centrum Medyczne AMED oddzial w Lodzi
Centrum Medyczne AMED Oddział w Łodzi
Centrum Medyczne AMED Warszawa Targowek
Dermatology
Foturemeds Warszawa Centrum
Future Meds Sp. z o. o.
FutureMeds
FutureMeds Targówek
Futuremeds - Krakow
Futuremeds - Targowek
Futuremeds - Wroclaw
FutureMeds Gdynia
FutureMeds Gdynia - site
FutureMeds Krakow
FutureMeds Kraków - site
FutureMeds Lodz
Futuremeds Łódź
FutureMeds Łódź - site
FutureMeds Olsztyn
FutureMeds Sp zoo
Futuremeds Sp. Z o.o
Futuremeds Targówek
FutureMeds Targówek - site
FutureMeds Warszawa Centrum
FutureMeds Warszawa Centrum - site
FutureMeds Warszawa Targówek
FutureMeds Warszawa Targówek - site
Futuremeds Wroclaw
FutureMeds Wroclaw - site
FutureMeds Wrocław
FutureMedz Olsztyn
Gastroenterology; New address: ul. Legnicka 16, 53-673, Wrocław, Polska
Gdynia
General medicine
Internal Medicine - Diabetioloy
Krakowskie Centrum Medyczne
Łódź
N/A
NA
ND
Nd.
Neurology
Non-public HealthCare Center
Not applicable
not applicable/nie dotyczy
Oncology
Practice
Rheumatology
Site name: FutureMeds Lódź
Site name: FutureMeds Targówek
Site name: FutureMeds Warszawa Centrum
Site name: FutureMeds Wroclaw
Targówek
unknown
Warszawa Centrum
Wrocław
ZOZ Poradnia Reumatyczna

Clinical trials at this site (164)

Search interface

The RADIAL study: A clinical trial to learn more about the benefits and the acceptability of trials that include technology to centre the tr… Ended

2022-500449-26-00 Type 2 diabetes mellitus (T2DM) 6 2023-08-03
UNITAS Ended

2022-502483-21-00 Insomnia disorder 4 2023-07-28
A Study of Olezarsen (ISIS 678354) in Participants With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease, or With Severe Hype… Ended

2022-503022-13-00 Hypertriglyceridemia, Cardiovascular Diseases, Atherosc 5 2023-06-08
A Study of Olezarsen Administered Subcutaneously to Participants With Severe Hypertriglyceridemia Ended

2022-501420-20-00 Severe hypertryglyceridemia 5 2023-05-17
Comparative efficacy, safety, pharmacokinetic, and immunogenicity study of LY06006 and EU-Prolia in postmenopausal women with osteoporosis Ended

2024-513591-18-00 Postmenopausal osteoporosis 5 2023-04-26
A study to test if izokibep improves psoriatic arthritis symptoms and to see how safe izokibep is Ended

2022-501362-22-00 Psoriatic Arthritis 10 2023-04-18
A study to learn how well the study treatment asundexian works and how safe it is compared to apixaban to prevent stroke or systemic embolis… Ended

2023-503794-38-00 Prevention of stroke or systemic embolism in atrial fib 5 2022-11-24
Phase 3, Placebo-Controlled, Efficacy, Safety, Tolerability, Immunogenicity, and Lot-Consistency Trial of a 6-Valent OspA-Based Lyme Disease… Ended

2023-509105-72-00 Active immunization against Lyme disease 5 2022-08-10
A study comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF5993 With the Fixed Dose Dual Combination CHF153… Ended

2023-510172-31-00 Chronic obstructive pulmonary disease (COPD) 5 2022-04-22
A Study of Olezarsen (ISIS 678354) Administered to Participants With Severe Hypertriglyceridemia. Ended

2024-510696-38-00 Severe Hypertriglyceridemia. 5 2022-03-08
A Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of HZN-825 in Patients with Diffuse Cutaneous Systemic Sclerosis Ended

2023-509782-20-00 Diffuse Cutaneous Systemic Sclerosis 4 2021-11-11
A multi site clinical trial to evaluate the efficacy and safety of Qutenza® in subjects with post-surgical neuropathic pain Ended

2024-514934-19-00 Post-surgical neuropathic pain 5 2021-11-08
A clinical study of tulisokibart for the treatment of ulcerative colitis (MK-7240-005) Ended

2023-509741-12-00 Ulcerative Colitis 4 2021-09-23
Research study on whether a combination of 2 medicines (NNC0194-0499 and Semaglutide) works in people with non-alcoholic steatohepatitis (NA… Ended

2023-506961-74-00 Non-alcoholic steatohepatitis (NASH) 4 2021-08-31
The efficacy and the safety of two doses of CHF6001 for the treatment of Chronic Obstructive Pulmonary Disease (COPD) Ended

2023-510175-60-00 Chronic obstructive pulmonary disease (COPD) and Chron 5 2021-06-16
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease Ended

2023-507303-55-00 Alzheimer Disease 4 2020-09-30
An extension study to learn if Bimekizumab works and is safe over a long period in adults with Active Axial Spondyloarthritis. Ended

2023-506527-28-00 Axial Spondyloarthritis 5 2020-06-29
Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke Ended

2023-503673-38-00 Adults at high risk of cardiovascular events without pr 5 2019-05-24
A Randomized, Double-blind, Parallel-group, Active-controlled Study to Compare the Efficacy, Pharmacokinetics, Pharmacodynamics, Safety, and… Ended

2024-512417-41-00 Osteoporosis 5
A randomized, phase 3 multicenter clinical trial to confirm the clinical efficacy and evaluate the safety of linaprazan glurate compared to … Ended

2025-522750-39-00 Erosive esophagitis (EE) due to gastroesophageal reflux 5